Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Allergy Clin Immunol. 2014 Oct 19;135(2):425–440. doi: 10.1016/j.jaci.2014.09.005

Figure 3. Effect of DNA-PK inhibition on OVA-induced production of Th1 and Th2 cytokines.

Figure 3

Assessment of BALF for IL-4, IL-5, eotaxin, IL-13, or IL-2 (A); IL-10 (B); IFN-γ (C); IL-12 (D); KC (E); or MCP-1 (F). Assessment of sera for MCP-1 (G). Data are means ± SD of values from at least six mice per group. *, difference from unchallenged mice; #, difference from OVA-challenged mice; p < 0.01.